{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:46:05Z","timestamp":1793256365194,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.kint.2022.08.039","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T11:02:22Z","timestamp":1666436542000},"page":"87-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Enhancer and super-enhancer landscape in polycystic kidney disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Ronak","family":"Lakhia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abheepsa","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Biggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Malladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cobo-Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Hajarnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2022.08.039_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MNH.0b013e3283262ab0","article-title":"Advances in the pathogenesis and treatment of polycystic kidney disease","volume":"18","author":"Patel","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2022.08.039_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12913-020-4974-4","article-title":"The societal economic burden of autosomal dominant polycystic kidney disease in the United States","volume":"20","author":"Cloutier","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.kint.2022.08.039_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2022.08.039_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.kint.2022.08.039_bib5","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPAR\u03b1 agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2022.08.039_bib6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41467-018-03036-y","article-title":"Lkb1 deficiency confers glutamine dependency in polycystic kidney disease","volume":"9","author":"Flowers","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2022.08.039_bib7","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmet.2021.03.024","article-title":"A\u00a0methionine-Mettl3-N(6)-methyladenosine axis promotes polycystic kidney disease","volume":"33","author":"Ramalingam","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2022.08.039_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133785","article-title":"Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression","volume":"5","author":"Lakhia","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.kint.2022.08.039_bib9","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.08.039_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2215\/CJN.06300615","article-title":"Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: results from the TEMPO 3:4 trial","volume":"11","author":"Torres","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.08.039_bib11","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2022.08.039_bib12","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41598-019-38566-y","article-title":"Anti-microRNA screen uncovers miR-17 family within miR-17\u223c92 cluster as the primary driver of kidney cyst growth","volume":"9","author":"Yheskel","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2022.08.039_bib13","doi-asserted-by":"crossref","first-page":"109548","DOI":"10.1016\/j.cellsig.2020.109548","article-title":"Modulation of polycystic kidney disease by non-coding RNAs","volume":"71","author":"Ramalingam","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2022.08.039_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrm3949","article-title":"The selection and function of cell type-specific enhancers","volume":"16","author":"Heinz","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.kint.2022.08.039_bib15","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2022.08.039_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nature09692","article-title":"A\u00a0unique chromatin signature uncovers early developmental enhancers in humans","volume":"470","author":"Rada-Iglesias","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.kint.2022.08.039_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","article-title":"Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma","volume":"24","author":"Chapuy","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.kint.2022.08.039_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.kint.2022.08.039_bib19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.kint.2022.08.039_bib20","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1172\/JCI121361","article-title":"Super-enhancers maintain renin-expressing cell identity and memory to preserve multi-system homeostasis","volume":"128","author":"Martinez","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2022.08.039_bib21","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41467-020-17205-5","article-title":"Enhancer and super-enhancer dynamics in repair after ischemic acute kidney injury","volume":"11","author":"Wilflingseder","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2022.08.039_bib22","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1038\/ncomms14395","article-title":"microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism","volume":"8","author":"Hajarnis","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2022.08.039_bib23","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1681\/ASN.2004110913","article-title":"Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease","volume":"16","author":"Le","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.08.039_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.kint.2017.08.005","article-title":"Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease","volume":"93","author":"Wang","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.039_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature09725","article-title":"Comprehensive analysis of the chromatin landscape in Drosophila melanogaster","volume":"471","author":"Kharchenko","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.kint.2022.08.039_bib26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A\u00a0critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2022.08.039_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.kint.2022.08.039_bib28","doi-asserted-by":"crossref","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","article-title":"The encyclopedia of DNA elements (ENCODE): data portal update","volume":"46","author":"Davis","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.kint.2022.08.039_bib29","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/s41467-021-22266-1","article-title":"Single cell regulatory landscape of the mouse kidney highlights cellular differentiation programs and disease targets","volume":"12","author":"Miao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2022.08.039_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature11082","article-title":"Topological domains in mammalian genomes identified by analysis of chromatin interactions","volume":"485","author":"Dixon","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.kint.2022.08.039_bib31","first-page":"219","article-title":"Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression","volume":"152","author":"Trudel","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2022.08.039_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ki.1991.80","article-title":"C-myc as an inducer of polycystic kidney disease in transgenic mice","volume":"39","author":"Trudel","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.039_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cell.2017.09.043","article-title":"Multiscale 3D genome rewiring during mouse neural development","volume":"171","author":"Bonev","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.kint.2022.08.039_bib34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.trecan.2018.10.003","article-title":"The MYC enhancer-ome: long-range transcriptional regulation of MYC in cancer","volume":"4","author":"Lancho","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.kint.2022.08.039_bib35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.039_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.kint.2022.08.039_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.molcel.2011.05.004","article-title":"Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes","volume":"42","author":"Cai","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.kint.2022.08.039_bib38","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.kint.2022.08.039_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2012.06.001","article-title":"Metabolic regulation of epigenetics","volume":"16","author":"Lu","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2022.08.039_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s42255-020-0227-4","article-title":"Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease","volume":"2","author":"Mi","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.kint.2022.08.039_bib41","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3389\/fmicb.2017.02686","article-title":"Hijacking of the AP-1 signaling pathway during development of ATL","volume":"8","author":"Gazon","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.kint.2022.08.039_bib42","first-page":"129","article-title":"The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation","volume":"1072","author":"Angel","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2022.08.039_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature25193","article-title":"A\u00a0Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies","volume":"553","author":"Bahr","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.kint.2022.08.039_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nn.4170","article-title":"Stimulus-specific combinatorial functionality of neuronal c-fos enhancers","volume":"19","author":"Joo","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.kint.2022.08.039_bib45","doi-asserted-by":"crossref","first-page":"939","DOI":"10.12688\/f1000research.11581.1","article-title":"Recent advances in high-throughput approaches to dissect enhancer function","volume":"6","author":"Santiago-Algarra","year":"2017","journal-title":"F1000Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382200847X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382200847X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:03:44Z","timestamp":1758762224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525382200847X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S008525382200847X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2022.08.039","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.19.469306","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancer and super-enhancer landscape in polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2022.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}